;
Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Arena, Eisai sales and marketing update

    Arena Pharmaceuticals Inc. (NASDAQ:ARNA), San Diego, Calif. Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Endocrine/Metabolic Arena said Eisai completed its increase of more than 200 sales representatives in its …

    Published on 7/21/2014
  • Enzymatics sales and marketing update

    Enzymatics Inc., Beverly, Mass. Business: Diagnostic Enzymatics launched worldwide the Archer FusionPlex Sarcoma Panel assay to detect and identify fusions of 26 genes associated with sarcoma. The assay uses Enzymatics …

    Published on 7/21/2014
  • kaleo sales and marketing update

    kaleo Inc., Richmond, Va. Business: Neurology kaleo launched Evzio naloxone in the U.S. for the emergency treatment of known or suspected opioid overdose. The product is a hand-held autoinjector that provides verbal …

    Published on 7/21/2014
  • Oxford Gene sales and marketing update

    Oxford Gene Technology, Oxford, U.K. Business: Diagnostic Oxford Gene launched the CytoSure Embryo Screen Array worldwide to improve embryo screening for in vitro fertilization (IVF). The high throughput genetic …

    Published on 7/21/2014
  • Upsher-Smith sales and marketing update

    Upsher-Smith Laboratories Inc., Maple Grove, Minn. Business: Neurology Upsher-Smith launched Qudexy XR topiramate extended-release capsules in the U.S. for seizures. Specifically, the drug is indicated as initial …

    Published on 7/21/2014
  • Veracyte sales and marketing update

    Veracyte Inc. (NASDAQ:VCYT), South San Francisco, Calif. Business: Diagnostic Veracyte said Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey, both affiliates of Blue Cross Blue Shield, issued positive …

    Published on 7/21/2014
  • Nanosphere Inc, HealthTrust Purchasing Group L.P. sales and marketing update

    Nanosphere Inc. (NASDAQ:NSPH), Northbrook, Ill. HealthTrust Purchasing Group L.P., Brentwood, Tenn. Business: Diagnostic Nanosphere signed an agreement with group purchasing organization HealthTrust to provide the …

    Published on 7/14/2014
  • Otsuka Pharmaceutical Co. Ltd sales and marketing update

    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Business: Pulmonary, Inflammation Otsuka launched Meptin Swinghaler procaterol in Japan to treat chronic obstructive pulmonary disease (COPD) and asthma. Meptin Swinghaler is…

    Published on 7/14/2014
  • Takeda Pharmaceutical Co. Ltd sales and marketing update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Cardiovascular Takeda launched Zacras azilsartan/amlodipine besylate in Japan to treat hypertension. The once-daily, fixed-dose combination of …

    Published on 7/14/2014
  • Apricus Biosciences, Takeda sales and marketing update

    Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Genitourinary Apricus said partner Takeda launched Vitaros alprostadil in the U.K. to treat …

    Published on 6/30/2014
  • Azanta, Medigene, Will-Pharma sales and marketing update

    Azanta A/S, Hellerup, Denmark Medigene AG (Xetra:MDG), Martinsried, Germany Will-Pharma, Wavre, Belgium Business: Infectious Medigene said partner Will-Pharma launched Veregen sinecatechins in Belgium to treat genital…

    Published on 6/30/2014
  • bioMerieux, Quest Diagnostics sales and marketing update

    bioMerieux S.A. (Euronext:BIM), Marcy lEtoile, France Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Business: Pharmacogenetics Quest launched bioMerieuxs THxID BRAF test in the U.S. to detect BRAF V600E and V600K …

    Published on 6/30/2014
  • Medivir sales and marketing update

    Medivir AB (SSE:MVIR B), Huddinge, Sweden Business: Infectious Medivir launched Olysio simeprevir in Sweden, Finland and Denmark and said the HCV drug will be available in all Nordic countries within the next few weeks…

    Published on 6/30/2014
  • Takeda sales and marketing update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Autoimmune Takeda launched Entyvio vedolizumab in the U.S. to treat moderate to severe ulcerative colitis (UC) and moderate to severe Crohns disease (…

    Published on 6/30/2014
  • Bio-Rad Laboratories Inc sales and marketing update

    Bio-Rad Laboratories Inc. (NYSE:BIO), Hercules, Calif. Business: Diagnostic Bio-Rad launched outside of the U.S. its BioPlex 2200 HIV Ag-Ab kit, which detects HIV antigens and antibodies and differentiates between HIV-1…

    Published on 6/23/2014
  • Cepheid Inc sales and marketing update

    Cepheid Inc. (NASDAQ:CPHD), Sunnyvale, Calif. Business: Diagnostic Cepheid launched its Xpert Carba-R test in countries that recognize CE Mark approval to detect carbapenemase-producing Gram-negative bacteria. The list …

    Published on 6/23/2014
  • Forest Laboratories Inc sales and marketing update

    Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Business: Neurology Forest said it will now continue marketing its 5 and 10 mg tablets of immediate-release Namenda memantine for Alzheimers disease into this fall to …

    Published on 6/23/2014
  • GenomeDx Biosciences Inc sales and marketing update

    GenomeDx Biosciences Inc., Vancouver, B.C. Business: Diagnostic GenomeDx said U.S. healthcare PPO network Prime Health Services Inc. will cover GenomeDxs Decipher Prostate Cancer Classifier. GenomeDx markets Decipher…

    Published on 6/23/2014
  • Invitae Corp sales and marketing update

    Invitae Corp., San Francisco, Calif. Business: Cancer Invitae launched its hereditary pancreatic cancer panel worldwide. The test, which analyzes 17 genes associated with an increased risk of pancreatic cancer with an …

    Published on 6/23/2014
  • Novo Nordisk A/ sales and marketing update

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic Novo Nordisk launched in the U.S. its Levemir FlexTouch, a prefilled disposable insulin pen containing Levemir insulin detemir, a …

    Published on 6/23/2014
  • Takeda Pharmaceutical Co. Ltd sales and marketing update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Gastrointestinal Takeda launched Takelda aspirin/lansoprazole fixed-dose combination tablets in Japan to reduce the risk of thrombosis and embolism in …

    Published on 6/23/2014
  • Tissue Regenix Group pl sales and marketing update

    Tissue Regenix Group plc (LSE:TRX), York, U.K. Business: Dermatology Tissue Regenix launched DermaPure in the U.S. to treat chronic wounds. Tissue Regenix also said it signed an exclusive government supplier agreement …

    Published on 6/23/2014
  • Vertex Pharmaceuticals Inc sales and marketing update

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. Business: Pulmonary Vertex signed a letter of intent with the pan-Canadian Pricing Alliance (pCPA) to enable public reimbursement of Kalydeco ivacaftor to treat …

    Published on 6/23/2014
  • Werfen Group S.A sales and marketing update

    Werfen Group S.A., Barcelona, Spain Business: Diagnostic Werfens Inova Diagnostics Inc. subsidiary launched its Quanta Lite Calprotectin assay worldwide to aid in diagnosing inflammatory bowel disease (IBD). The …

    Published on 6/23/2014
  • Chembio sales and marketing update

    Chembio Diagnostics Inc. (NASDAQ:CEMI), Medford, N.Y. Business: Diagnostic Chembio launched its DPP HIV 1/2 Assay and corresponding DPP HIV 1/2 Control Pack in the U.S. for HIV detection. The assay is an …

    Published on 6/16/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993